Pailin Bio shareholder Harbin Tongzhicheng Technology Development Co., Ltd. released 26 million shares from pledge on July 24, accounting for 24.88% of its holdings and 2.74% of the company's total share capital. It subsequently arranged a new pledge of 31.8 million shares, representing 30.43% of its holdings and 3.35% of the company's total share capital. As of the announcement date, Tongzhicheng Technology's cumulative pledged shares stood at 47.63 million shares, accounting for 45.58% of its total holdings and 5.01% of the company's total share capital. In the first quarter of 2026, Pailin Bio recorded revenue of 343 million yuan and net profit attributable to the parent company of 22.97 million yuan.
Pacific Shuanglin Bio pharmacy Co LtdMajor shareholder pledges and releases shares, indicating potential financing needs but no direct impact on operations.
The company itself is the shareholder executing the pledge and release, reflecting its own financing activity.